Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Spatial multiomics integration sits at the intersection of tissue-section imaging, molecular barcoding and computational alignment: methods for reading out multiple molecular layers — DNA, RNA, protein — from the same tissue section and then registering those readouts against one another and against physical position. The claim language in this dataset clusters around two mechanics: how the assay converts a biological signal into a measurable format (recoding protein sequence into DNA, barcoding macromolecules inside individual cells) and how sparse, multi-modal measurements get reconciled across sections, cells and assay runs. Sample throughput, assay compatibility and cross-modality alignment are recurring claim elements rather than background language, which is why this search string surfaces a narrow, technically coherent set of 32 records rather than a broad omics dump.
Filing activity is concentrated in a short window, peaking at 17 records in 2023, and publication lag means the last one to two years understate true filing volume. The assignee base is small and unevenly distributed: one organisation accounts for 21 of the ranked records, while most others appear once or twice, which points to a field still being staked out rather than one with settled competitive lines.
Pick a task. Every answer cites the patents behind it.
The 32 records in scope split across eight IPC subclasses and six receiving offices, with the United States taking the largest single share of filings and G01N and C12Q covering the majority of records between them.
Filings were essentially absent before the field's technical vocabulary matured, rose to a peak of 17 in 2023, and the most recent year is necessarily undercounted because publication runs roughly 18 months behind filing.
G01N (material analysis and testing) appears in 59.4% of the 32 records and C12Q (enzyme/DNA-based measurement) in 56.3%, together forming the technical core; combinatorial library methods under C40B reach 21.9%, while bioinformatics-specific claims under G16B sit at just 6.3% of records, a small share for a field whose value depends on computational cross-modality alignment.
Shares are the percentage of the 32 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about spatial multiomics integration and every answer comes back with the patent numbers behind it.
Try EurekaThe present disclosure features methods for modifying fertility. In some embodiments, the disclosure provides contraceptive compositions and methods of using the same.Filed by The Broad Institute, Inc.; published 2026-02-05. Its presence in this dataset reflects the shared molecular-profiling and modality toolkit rather than a therapeutic-fertility focus.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO2024015875A2 | Determination of protein information by recoding amino acid polymers into DNA polymers | 7 |
| 2 | US20250020657A1 | Determination of protein information by recoding amino acid polymers into DNA polymers | 6 |
| 3 | US12188940B2 | Determination of protein information by recoding amino acid polymers into DNA polymers | 6 |
| 4 | US20230332215A1 | Methods for barcoding macromolecules in individual cells | 5 |
| 5 | WO2024040236A2 | Determination of protein information by recoding amino acid polymers into DNA polymers | 4 |
| 6 | US20240044909A1 | Determination of protein information by recoding amino acid polymers into DNA polymers | 4 |
| 7 | WO2024050541A1 | Systems and methods for diagnosing a disease or a condition | 3 |
| 8 | US12038443B2 | Determination of protein information by recoding amino acid polymers into DNA polymers | 3 |
| 9 | WO2023086847A1 | Methods for barcoding macromolecules in individual cells | 3 |
| 10 | US20230143290A1 | Methods for barcoding macromolecules in individual cells | 3 |
Citation counts are drawn from a searched corpus and favour older, earlier-published records; treat them as a signal of influence on later filings, not as a measure of current commercial importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three patterns stand out once family counts, citation concentration and classification shares are read together.
The leading assignee holds 21 of the ranked records; fifth place holds only 2. That gap is wide enough that a new entrant is not really contesting a crowded middle field, but deciding whether to file adjacent to a single dominant portfolio or to look elsewhere entirely.
The most-cited record and its related family members all describe recoding amino-acid polymer information into DNA polymers for readout — a mechanic that later filings appear to cite repeatedly, making it the closest thing this dataset has to a foundational claim.
Assay-side classes (G01N, C12Q, C40B) cover the bulk of records, but bioinformatics-specific claims sit at only 6.3% of the 32 records. For a field defined by reconciling sparse multi-modal signals, the computational-alignment layer looks thinly staked.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to spatial multiomics integration, with the prior art for and against each one.
The ranked assignee list is short — 21 organisations in total — and dominated by academic and research institutions rather than diagnostics or platform companies, with momentum for every tracked assignee flat or down in the latest year once publication lag is accounted for.
One organisation's filings account for the large majority of the ranked activity, spanning protein-recoding and macromolecule-barcoding methods. Co-assignee pairings in the dataset also route back to this same organisation working alongside other research institutions.
Beyond the leader, filing counts drop off quickly — fifth place holds only 2 records and tenth place just 1. This is typical of a field still in an exploratory phase, where individual labs and small entities stake narrow method claims rather than building broad portfolios.
Ten co-assignee pairs appear in the dataset, several repeating around the same lead institution paired with different partner universities and hospitals — evidence of shared research programmes rather than independent competing filings.
| Assignee | Recent year | YoY |
|---|---|---|
| Abrus Bio, Inc. | 0 | -100% |
| Encodia, Inc. | 0 | -100% |
| Massachusetts Institute of Technology | 0 | -100% |
| The General Hospital Corporation | 0 | -100% |
| Trustees of Dartmouth College | 0 | -100% |
| Icahn School of Medicine at Mount Sinai | 0 | — |
| Northwestern University | 0 | -100% |
| The Broad Institute, Inc. | 0 | -100% |
The figures above describe what has been filed; the next step is testing a specific claim or design-around against the full family text.
The protein-recoding-to-DNA-polymer claims cited most often in this dataset are a natural starting point for a freedom-to-operate check before committing to a similar readout mechanic.
Explore this family in EurekaBioinformatics and cross-modality alignment classes are thinly represented relative to assay-mechanics classes; a claim drafted in that gap may face less prior art.
Run a white-space search in EurekaWith one assignee holding 21 of 32 ranked records, watching its continuation and new-filing activity is a reasonable proxy for where the field's centre of gravity moves next.
Monitor this assignee in EurekaOne research institute leads the ranked assignee list with 21 of the 32 records in this dataset, a considerable margin over the rest of the field — fifth place holds only 2 records. The gap suggests the field has one dominant early filer rather than several competing portfolios of similar size. Most other organisations in the ranking, which covers 21 companies in total, appear with just one or two records, typical of an area still being explored rather than consolidated.
The claims in this dataset centre on converting biological signal into measurable format — for example recoding amino-acid polymer sequence into DNA polymers, or barcoding macromolecules inside individual cells — and on reconciling sparse, multi-modal readouts across tissue sections. Classification data shows G01N (material analysis and testing) and C12Q (enzyme/DNA-based measurement) covering the majority of the 32 records, with smaller shares in combinatorial chemistry libraries, bioinformatics and medicinal preparations. This points to an assay-mechanics-heavy field rather than a purely computational one.
Filing volume in this dataset was negligible in the earlier years covered (2017 onward) and rose to a peak of 17 records in 2023, the highest single year on record here. Because patent publication typically lags filing by around 18 months, the most recent year or two in any such trend will understate actual filing activity, so 2023 may not remain the true peak once later filings publish. There are too few complete years after accounting for that lag to state a reliable growth rate.
Relative to the assay-mechanics classes that dominate this dataset, computational and workflow-adjacent classes are thin: bioinformatics-specific claims (G16B) appear in only 6.3% of the 32 records, and cross-modality alignment, section registration and measurement-sparsity correction are recurring search terms but not heavily represented as dedicated IPC classifications. A first claim in one of those areas would likely describe a specific alignment or registration algorithm tied to a named data type, rather than a general assay chemistry.
Concentration cannot be stated as a clean percentage here because the assignee ranking and the total record count are measured in different units, but the shape of the ranking is informative on its own: one assignee holds 21 records, fifth place holds 2, and tenth place holds just 1. That drop-off, combined with 10 identified co-assignee pairings clustering around the same lead institution, suggests a field anchored by one research group's programme and its academic collaborators, with room for new entrants outside that cluster.
Go past this page: query the whole spatial multiomics integration corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.
Help us improve
Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.
This page